The FDA last month accepted the application for subcutaneous Leqembi for maintenance dosing, with a target action date of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback